Table of Contents
Journal of Amino Acids
Volume 2014, Article ID 964680, 10 pages
http://dx.doi.org/10.1155/2014/964680
Research Article

Tissue Taurine Depletion Alters Metabolic Response to Exercise and Reduces Running Capacity in Mice

1Department of Clinical Pharmacogenomics, School of Pharmacy, Hyogo University of Health Sciences, Kobe, Hyogo 650-8530, Japan
2Department of Pharmacology, University of South Alabama College of Medicine, Mobile, AL 36688, USA

Received 1 June 2014; Revised 20 October 2014; Accepted 20 October 2014; Published 12 November 2014

Academic Editor: Carlo Chiarla

Copyright © 2014 Takashi Ito et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Ito, Y. Kimura, Y. Uozumi et al., “Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy,” Journal of Molecular and Cellular Cardiology, vol. 44, no. 5, pp. 927–937, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. U. Warskulat, U. Flögel, C. Jacoby et al., “Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised,” The FASEB Journal, vol. 18, no. 3, pp. 577–579, 2004. View at Google Scholar · View at Scopus
  3. R. Dawson Jr., M. Biasetti, S. Messina, and J. Dominy, “The cytoprotective role of taurine in exercise-induced muscle injury,” Amino Acids, vol. 22, no. 4, pp. 309–324, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Miyazaki, Y. Matsuzaki, T. Ikegami et al., “The harmful effect of exercise on reducing taurine concentration in the tissues of rats treated with CC14 administration,” Journal of Gastroenterology, vol. 39, no. 6, pp. 557–562, 2004. View at Google Scholar · View at Scopus
  5. D. C. Camerino, D. Tricarico, S. Pierno et al., “Taurine and skeletal muscle disorders,” Neurochemical Research, vol. 29, no. 1, pp. 135–142, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Matsuzaki, N. Tanaka, and T. Osuga, “Is taurine effective for treatment of painful muscle cramps in liver cirrhosis?” The American Journal of Gastroenterology, vol. 88, no. 9, pp. 1466–1467, 1993. View at Google Scholar · View at Scopus
  7. Y. Uozumi, T. Ito, Y. Hoshino et al., “Myogenic differentiation induces taurine transporter in association with taurine-mediated cytoprotection in skeletal muscles,” Biochemical Journal, vol. 394, no. 3, pp. 699–706, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Schaffer, K. Takahashi, and J. Azuma, “Role of osmoregulation in the actions of taurine,” Amino Acids, vol. 19, no. 3-4, pp. 527–546, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. S. W. Schaffer, J. Azuma, and M. Mozaffari, “Role of antioxidant activity of taurine in diabetes,” Canadian Journal of Physiology and Pharmacology, vol. 87, no. 2, pp. 91–99, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. A. De Luca, S. Pierno, and D. C. Camerino, “Effect of taurine depletion on excitation-contraction coupling and Cl-conductance of rat skeletal muscle,” European Journal of Pharmacology, vol. 296, no. 2, pp. 215–222, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Ito, S. Oishi, M. Takai et al., “Cardiac and skeletal muscle abnormality in taurine transporter-knockout mice,” Journal of Biomedical Science, vol. 17, supplement 1, article S20, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. M. Sanchez, R. B. Candau, A. Csibi, A. F. Pagano, A. Raibon, and H. Bernardi, “The role of AMP-activated protein kinase in the coordination of skeletal muscle turnover and energy homeostasis,” American Journal of Physiology: Cell Physiology, vol. 303, no. 5, pp. C475–C485, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. M. S. Mozaffari, B. H. Tan, M. A. Lucia, and S. W. Schaffer, “Effect of drug-induced taurine depletion on cardiac contractility and metabolism,” Biochemical Pharmacology, vol. 35, no. 6, pp. 985–989, 1986. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Kirino, T. Yasukawa, S. Ohta et al., “Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 42, pp. 15070–15075, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Weixlbaumer, F. V. Murphy IV, A. Dziergowska et al., “Mechanism for expanding the decoding capacity of transfer RNAs by modification of uridines,” Nature Structural & Molecular Biology, vol. 14, no. 6, pp. 498–502, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. S. W. Schaffer, C. J. Jong, D. Warner, T. Ito, and J. Azuma, “Taurine deficiency and MELAS are closely related syndromes,” Advances in Experimental Medicine and Biology, vol. 776, pp. 153–165, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. C. J. Jong, T. Ito, M. Mozaffari, J. Azuma, and S. Schaffer, “Effect of -alanine treatment on mitochondrial taurine level and 5-taurinomethyluridine content,” Journal of Biomedical Science, vol. 17, supplement 1, article S25, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Ito, N. Yoshikawa, T. Inui, N. Miyazaki, S. W. Schaffer, and J. Azuma, “Tissue depletion of taurine accelerates skeletal muscle senescence and leads to early death in mice,” PLoS ONE, vol. 9, no. 9, Article ID e107409, 2014. View at Publisher · View at Google Scholar
  19. K. Okamoto, W. Wang, J. Rounds, E. A. Chambers, and D. O. Jacobs, “ATP from glycolysis is required for normal sodium homeostasis in resting fast-twitch rodent skeletal muscle,” American Journal of Physiology: Endocrinology and Metabolism, vol. 281, no. 3, pp. E479–E488, 2001. View at Google Scholar · View at Scopus
  20. A. Zhu, R. Romero, and H. R. Petty, “Amplex UltraRed enhances the sensitivity of fluorimetric pyruvate detection,” Analytical Biochemistry, vol. 403, no. 1-2, pp. 123–125, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Ito, Y. Fujio, and M. Hirata, “Expression of taurine transporter is regulated through the TonE (tonicity-responsive element)/TonEBP (TonE-binding protein) pathway and contributes to cytoprotection in HepG2 cells,” The Biochemical Journal, vol. 382, pp. 177–182, 2004. View at Publisher · View at Google Scholar
  22. R. S. Lee-Young, S. R. Griffee, S. E. Lynes et al., “Skeletal muscle AMP-activated protein kinase is essential for the metabolic response to exercise in vivo,” The Journal of Biological Chemistry, vol. 284, no. 36, pp. 23925–23934, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Suzuki, S. Okamoto, S. Lee, K. Saito, T. Shiuchi, and Y. Minokoshi, “Leptin stimulates fatty acid oxidation and peroxisome proliferator-activated receptor α gene expression in mouse C2C12 myoblasts by changing the subcellular localization of the α2 form of AMP-activated protein kinase,” Molecular and Cellular Biology, vol. 27, no. 12, pp. 4317–4327, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. G. R. Steinberg, H. M. O'Neill, N. L. Dzamko et al., “Whole body deletion of AMP-activated protein kinase β2 reduces muscle AMPK activity and exercise capacity,” The Journal of Biological Chemistry, vol. 285, no. 48, pp. 37198–37209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Miyazaki, Y. Matsuzaki, T. Ikegami et al., “Optimal and effective oral dose of taurine to prolong exercise performance in rat,” Amino Acids, vol. 27, no. 3-4, pp. 291–298, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Cuisinier, J. M. de Welle, R. K. Verbeeck et al., “Role of taurine in osmoregulation during endurance exercise,” European Journal of Applied Physiology, vol. 87, no. 6, pp. 489–495, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. U. Maitra, N. Singh, L. Gan, L. Ringwood, and L. Li, “IRAK-1 contributes to lipopolysaccharide-induced reactive oxygen species generation in macrophages by inducing NOX-1 transcription and Rac1 activation and suppressing the expression of antioxidative enzymes,” Journal of Biological Chemistry, vol. 284, no. 51, pp. 35403–35411, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. L. M. Sanderson, T. Degenhardt, A. Koppen et al., “Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) but not PPARα serves as a plasma free fatty acid sensor in liver,” Molecular and Cellular Biology, vol. 29, no. 23, pp. 6257–6267, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Zhang, S. L. Marcus, K. S. Miyata, S. Subramani, J. P. Capone, and R. A. Rachubinski, “Characterization of protein-DNA interactions within the peroxisome proliferator-responsive element of the rat hydratase-dehydrogenase gene,” The Journal of Biological Chemistry, vol. 268, no. 17, pp. 12939–12945, 1993. View at Google Scholar · View at Scopus
  30. J. R. Neely and H. E. Morgan, “Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle,” Annual Review of Physiology, vol. 36, pp. 413–459, 1974. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Larsen, J. M. Kristensen, N. Stride, J. F. P. Wojtaszewski, J. W. Helge, and F. Dela, “Skeletal muscle mitochondrial respiration in AMPKα2 kinase-dead mice,” Acta Physiologica, vol. 205, no. 2, pp. 314–320, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. H. M. O'Neill, S. J. Maarbjerg, J. D. Crane et al., “AMP-activated protein kinase (AMPK) β1β2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 38, pp. 16092–16097, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Suzuki, T. Wada, K. Saigo, and K. Watanabe, “Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases,” The EMBO Journal, vol. 21, no. 23, pp. 6581–6589, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. A. M. James, P. W. Sheard, Y.-H. Wei, and M. P. Murphy, “Decreased ATP synthesis is phenotypically expressed during increased energy demand in fibroblasts containing mitochondrial tRNA mutations,” European Journal of Biochemistry, vol. 259, no. 1-2, pp. 462–469, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Umeda, T. Suzuki, M. Yukawa, Y. Ohya, H. Shindo, and K. Watanabe, “Mitochondria-specific RNA-modifying enzymes responsible for the biosynthesis of the wobble base in mitochondrial tRNAs: implications for the molecular pathogenesis of human mitochondrial diseases,” Journal of Biological Chemistry, vol. 280, no. 2, pp. 1613–1624, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Anitori, K. Manning, F. Quan et al., “Contrasting phenotypes in three patients with novel mutations in mitochondrial tRNA genes,” Molecular Genetics and Metabolism, vol. 84, no. 2, pp. 176–188, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Takeda, S. Chiba, I. Takaaki, A. Tanamura, Y. Yamaguchi, and N. Takeda, “Cell cycle of myocytes of cardiac and skeletal muscle in mitochondrial myopathy,” Japanese Circulation Journal, vol. 62, no. 9, pp. 695–699, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. D. M. Muoio, P. S. MacLean, D. B. Lang et al., “Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) α knock-out mice. Evidence for compensatory regulation by PPARδ,” The Journal of Biological Chemistry, vol. 277, no. 29, pp. 26089–26097, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. V. A. Narkar, M. Downes, R. T. Yu et al., “AMPK and PPARδ agonists are exercise mimetics,” Cell, vol. 134, no. 3, pp. 405–415, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. A. M. van Berendoncks, A. Garnier, P. Beckers et al., “Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure,” Circulation: Heart Failure, vol. 3, no. 2, pp. 185–194, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Lantier, R. Mounier, J. Leclerc, M. Pende, M. Foretz, and B. Viollet, “Coordinated maintenance of muscle cell size control by AMP-activated protein kinase,” The FASEB Journal, vol. 24, no. 9, pp. 3555–3561, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Mounier, L. Lantier, J. Leclerc, A. Sotiropoulos, M. Foretz, and B. Viollet, “Antagonistic control of muscle cell size by AMPK and mTORC1,” Cell Cycle, vol. 10, no. 16, pp. 2640–2646, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. S. E. Gordon, J. A. Lake, C. M. Westerkamp, and D. M. Thomson, “Does AMP-activated protein kinase negatively mediate aged fast-twitch skeletal muscle mass?” Exercise and Sport Sciences Reviews, vol. 36, no. 4, pp. 179–186, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Takatani, K. Takahashi, Y. Uozumi et al., “Taurine inhibits apoptosis by preventing formation of the Apaf-1/caspase-9 apoptosome,” American Journal of Physiology: Cell Physiology, vol. 287, no. 4, pp. C949–C953, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Fernandez, O. Hansson, P. Nevsten, C. Holm, and C. Klint, “Hormone-sensitive lipase is necessary for normal mobilization of lipids during submaximal exercise,” American Journal of Physiology: Endocrinology and Metabolism, vol. 295, no. 1, pp. E179–E186, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. J. M. Irimia, C. M. Meyer, C. L. Peper et al., “Impaired glucose tolerance and predisposition to the fasted state in liver glycogen synthase knock-out mice,” The Journal of Biological Chemistry, vol. 285, no. 17, pp. 12851–12861, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. B. A. Pederson, C. M. Cope, J. M. Schroeder et al., “Exercise capacity of mice genetically lacking muscle glycogen synthase: in mice, muscle glycogen is not essential for exercise,” The Journal of Biological Chemistry, vol. 280, no. 17, pp. 17260–17265, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. K. M. Baldwin, R. H. Fitts, F. W. Booth, W. W. Winder, and J. O. Holloszy, “Depletion of muscle and liver glycogen during exercise. Protective effect of training,” Pflügers Archiv European Journal of Physiology, vol. 354, no. 3, pp. 203–212, 1975. View at Publisher · View at Google Scholar · View at Scopus